Clinical Trials Browser

Phase 2 × Interventional × Electroporation Therapies × Clear all

NCT03603808 2025-07-16

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

Phase 2 Completed

Squamous Intraepithelial Lesions, HIV Seropositivity

NCT03823131 2023-05-09

Optimizing Antitumor Immunity Using Plasmid Electroporation, Pembrolizumab, and Epacadostat

Phase 2 Terminated

14 enrolled 12 charts

Squamous Cell Carcinoma of Head and Neck